130. Switzerland supports the introduction of a non-burdensome requirement into the TRIPS Agreement to disclose the source of genetic resources in patent applications for inventions directly based on a genetic resource. Introducing such a requirement makes in our view sense, when we also accept the principle of patentability of biotechnological inventions. 131. In cooperation with the W/52 coalition (TN/C/W/52), a group of 109 WTO Members, Switzerland has submitted modalities proposals for three outstanding implementation issues at TNC level, next to the GI register and GI extension, these proposals including on a disclosure requirement for genetic resources and traditional knowledge in patent applications. 132. These outstanding TRIPS implementation issues should be included in any future work programme of the WTO in view of finding appropriate solutions for them. 133. The Council's discussion under agenda items 3, 4 and 5 can helpfully contribute to this objective. Sharing fact-based experience among Members enhance our understanding of what is at stake and of how the WTO should address best the interests and concerns of Members. 134. Finally, my delegation can agree with the two proposals made - to request the Secretariat to update its three factual briefs under the triplet agenda items, and to invite the Secretariat of the CBD to give a briefing on the Nagoya Protocol to the TRIPS Council.
© World Trade Organization 2023
ver 126.96.36.1995 (18/10/2023 12:29 AM)